Polypharmacy in the senior pet: managing several drugs

Every molecule introduced into the body is absorbed, transformed and eliminated, almost always passing through the liver and kidneys. In the senior animal these organs often work below full efficiency, and they are precisely the ones some drugs can strain. Adding a treatment therefore means not only hoping for a benefit, but weighing how it combines with everything else: two drugs acting on the same system can add up their side effects, and one can change the speed at which another is eliminated, pushing its concentration above or below the useful window.

This is why the golden rule of polypharmacy is that no drug, not even a supplement or an over the counter product, enters the plan without going through the vet who holds the full picture. An anti inflammatory bought on one's own initiative to help a limping dog can be dangerous if the animal already has reduced kidney function or takes other molecules that interact. An up to date list of everything the animal takes, including seemingly harmless things, is the first safety tool.

The most common cause of error at home is not a lack of attention, but a plan kept in the head. With three or four drugs at different times, the mind relies on memories that blur, especially if several people take turns in the care. A written, visible plan organised by moment of the day rather than by drug removes much of this error.

Organising the plan by moment of the day rather than by single drug has a huge practical advantage: whoever gives the medicine looks at one line, the one for the current time, and knows exactly what to give now. A list by drug instead forces a reconstruction each time of which have already been given, and it is precisely in that reconstruction that double and missed doses arise.

When several people care for the same senior animal, managing the drugs becomes teamwork, and like any teamwork it needs a shared point of truth rather than a tangle of messages. A few simple habits sharply cut the risk of error.

1. 1

   Keep a single, up to date list

   Drug name, dose, times, with or without food, and reason. Update it at every change and bring it to every visit.

2. 2

   Mark each dose as soon as it is given

   A tick straight after avoids the have I already given it question. Short term memory is unreliable on repeated actions.

3. 3

   Use reminders linked to the animal's record

   An alert for each time reduces skipped doses, and a shared history stops two people giving the same dose.

4. 4

   Pre load a pill organiser only if the vet confirms it

   Some tablets must not be split or mixed. Ask first whether advance preparation is safe for those drugs.

5. 5

   Agree who does what when there are several carers

   One person responsible per time slot avoids the double dose from each assuming the other did it.

6. 6

   Note the observed effects

   Appetite, vomiting, drowsiness, mobility: short dated notes help the vet judge whether the plan needs changing.

Recording the observed effects is not a detail: it is the information that lets the vet tell a worsening of the disease from a side effect of the drug. Drowsiness that appeared the day after a molecule was added tells a different story from drowsiness present for weeks, and only a dated note preserves that difference until the visit.

A treatment plan is not a monument. The senior animal's condition changes, some treatments become pointless, others need adjusting to falling weight or to the changing function of an organ. A periodic review of the whole list, not just the problem of the moment, is part of good geriatric management and should be asked for explicitly if it is not offered.

• Whether it is still really needed: some drugs stay in the plan by inertia when the reason that introduced them has passed.
• Whether the dose is still correct: an animal that has lost weight may be getting an amount now excessive for its current size.
• Whether tests confirm safety: kidney and liver values guide the choice to continue, reduce or change molecule.
• Whether the dosing is sustainable: a plan that is too complex is followed poorly, and simplifying it improves real adherence.
• Whether the benefits outweigh the burden of care: in advanced stages the aim shifts to comfort, and some treatments should be rediscussed in that light.